EMA-话题@MedSci

#EMA#

580篇内容 | 2471人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317534, encodeId=c8e7131e5346a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：UM171扩增脐血干细胞移植, objectType=article, longId=182591, objectId=d516182591e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d516182591e9, replyNumber=0, likeNumber=52, createdTime=2019-11-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d516182591e9, moduleTitle=Lancet Haematol：UM171扩增脐血干细胞移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d516182591e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317533, encodeId=cc11131e53392, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：如何评估肥大细胞增多症患者的预后？, objectType=article, longId=182244, objectId=6b5518224444, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b5518224444, replyNumber=0, likeNumber=70, createdTime=2019-11-03, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b5518224444, moduleTitle=Lancet haemat：如何评估肥大细胞增多症患者的预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b5518224444)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317532, encodeId=df39131e53271, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Emanue－综合征胎儿一例（产前诊断、NT增厚）, objectType=article, longId=182057, objectId=347118205e47, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=347118205e47, replyNumber=0, likeNumber=59, createdTime=2019-10-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=347118205e47, moduleTitle=Emanue－综合征胎儿一例（产前诊断、NT增厚）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=347118205e47)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317531, encodeId=1501131e5311e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=蓝鸟生物生产规范获EMA批准基因疗法Zynteglo准备上市！, objectType=article, longId=181935, objectId=f4c8181935c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4c8181935c7, replyNumber=0, likeNumber=60, createdTime=2019-10-27, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4c8181935c7, moduleTitle=蓝鸟生物生产规范获EMA批准基因疗法Zynteglo准备上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4c8181935c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317530, encodeId=0639131e53026, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=胡夕春教授：MONARCH plus研究——Abemaciclib给中国HR+/HER2-晚期乳腺癌患者带来新的希望, objectType=article, longId=181756, objectId=a252181e564c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a252181e564c, replyNumber=0, likeNumber=56, createdTime=2019-10-24, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a252181e564c, moduleTitle=胡夕春教授：MONARCH plus研究——Abemaciclib给中国HR+/HER2-晚期乳腺癌患者带来新的希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a252181e564c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317528, encodeId=b6a5131e5288a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=2019 ESMO|内分泌治疗是激素受体阳性乳腺癌重要的治疗手段，Abemaciclib显著延长HR+/HER2-mBC患者PFS, objectType=article, longId=181298, objectId=eae9181298b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eae9181298b0, replyNumber=0, likeNumber=52, createdTime=2019-10-17, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eae9181298b0, moduleTitle=2019 ESMO|内分泌治疗是激素受体阳性乳腺癌重要的治疗手段，Abemaciclib显著延长HR+/HER2-mBC患者PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eae9181298b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317527, encodeId=4b4f131e52772, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：苏消安联合氟达拉滨用于异基因造血干细胞移植术前处理, objectType=article, longId=180921, objectId=5b5618092125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b5618092125, replyNumber=0, likeNumber=64, createdTime=2019-10-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b5618092125, moduleTitle=Lancet Haematol：苏消安联合氟达拉滨用于异基因造血干细胞移植术前处理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b5618092125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317526, encodeId=895f131e526d6, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=BMJ：2014-16年间EMA批准抗肿瘤药物临床关键试验偏倚风险研究, objectType=article, longId=179936, objectId=fca71e993682, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fca71e993682, replyNumber=0, likeNumber=65, createdTime=2019-09-25, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fca71e993682, moduleTitle=BMJ：2014-16年间EMA批准抗肿瘤药物临床关键试验偏倚风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fca71e993682)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317525, encodeId=a971131e525c4, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA：人用药品中应避免存在亚硝胺杂质, objectType=article, longId=179523, objectId=eef01e95233d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eef01e95233d, replyNumber=0, likeNumber=63, createdTime=2019-09-17, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eef01e95233d, moduleTitle=EMA：人用药品中应避免存在亚硝胺杂质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eef01e95233d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317524, encodeId=5337131e524ce, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Stem Cells Int：干细胞片和Bio-Oss®骨颗粒复合物联合semaphorin 3A 可用于治疗2型糖尿病患者的骨丧失, objectType=article, longId=178760, objectId=69df1e87603b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69df1e87603b, replyNumber=0, likeNumber=86, createdTime=2019-09-05, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69df1e87603b, moduleTitle=Stem Cells Int：干细胞片和Bio-Oss®骨颗粒复合物联合semaphorin 3A 可用于治疗2型糖尿病患者的骨丧失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69df1e87603b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317523, encodeId=b904131e523ca, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：全膝关节置换的患者预防静脉血栓栓塞的更佳措施, objectType=article, longId=178323, objectId=cde01e8323a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cde01e8323a1, replyNumber=0, likeNumber=87, createdTime=2019-08-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cde01e8323a1, moduleTitle=Lancet haemat：全膝关节置换的患者预防静脉血栓栓塞的更佳措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cde01e8323a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317522, encodeId=3063131e5229b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet：Fremangezumab用于顽固性偏头痛预防, objectType=article, longId=178014, objectId=a1531e801432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1531e801432, replyNumber=0, likeNumber=59, createdTime=2019-08-22, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1531e801432, moduleTitle=Lancet：Fremangezumab用于顽固性偏头痛预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1531e801432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317521, encodeId=6d7e131e521d0, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：纳武单抗联合伊达比星和阿糖胞苷可提高AML或高风险MDS患者预后, objectType=article, longId=177371, objectId=98671e7371f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98671e7371f8, replyNumber=0, likeNumber=60, createdTime=2019-08-11, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98671e7371f8, moduleTitle=Lancet haemat：纳武单抗联合伊达比星和阿糖胞苷可提高AML或高风险MDS患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98671e7371f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317520, encodeId=71c5131e52097, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematology：Nivolumab联合一线化疗治疗急性髓系白血病, objectType=article, longId=177285, objectId=c6391e7285a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6391e7285a6, replyNumber=0, likeNumber=50, createdTime=2019-08-10, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6391e7285a6, moduleTitle=Lancet Haematology：Nivolumab联合一线化疗治疗急性髓系白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6391e7285a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317519, encodeId=618f131e5198c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA建议批准Vitrakvi治疗NTRK基因融合的实体瘤患者, objectType=article, longId=176376, objectId=d5511e6376a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5511e6376a5, replyNumber=0, likeNumber=65, createdTime=2019-07-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5511e6376a5, moduleTitle=EMA建议批准Vitrakvi治疗NTRK基因融合的实体瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5511e6376a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317518, encodeId=d6be131e5187f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Aridis柠檬酸镓吸入剂AR-501治疗囊性纤维化肺部感染，喜获EMA孤儿药物指定, objectType=article, longId=175954, objectId=2cb91e5954e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cb91e5954e9, replyNumber=0, likeNumber=68, createdTime=2019-07-24, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cb91e5954e9, moduleTitle=Aridis柠檬酸镓吸入剂AR-501治疗囊性纤维化肺部感染，喜获EMA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cb91e5954e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317517, encodeId=4dc5131e5178a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA药物警戒风险评估委员会将严格控制患者对甲氨蝶呤和环丙孕酮的服用, objectType=article, longId=175686, objectId=a42b1e5686c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a42b1e5686c6, replyNumber=0, likeNumber=84, createdTime=2019-07-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a42b1e5686c6, moduleTitle=EMA药物警戒风险评估委员会将严格控制患者对甲氨蝶呤和环丙孕酮的服用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a42b1e5686c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317516, encodeId=c9e6131e51687, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol:肺鳞癌新进展！上海市肺科医院周彩存团队在肺鳞癌免疫和基因图谱研究方面取得新进展！, objectType=article, longId=175520, objectId=19621e552023, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19621e552023, replyNumber=0, likeNumber=64, createdTime=2019-07-17, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19621e552023, moduleTitle=J Hematol Oncol:肺鳞癌新进展！上海市肺科医院周彩存团队在肺鳞癌免疫和基因图谱研究方面取得新进展！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19621e552023)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317515, encodeId=066c131e51502, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematology & Oncology：肺鳞癌新进展！上海市肺科医院周彩存团队在肺鳞癌免疫和基因图谱研究方面取得新进展！, objectType=article, longId=175410, objectId=3a911e54109d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a911e54109d, replyNumber=0, likeNumber=65, createdTime=2019-07-15, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a911e54109d, moduleTitle=J Hematology & Oncology：肺鳞癌新进展！上海市肺科医院周彩存团队在肺鳞癌免疫和基因图谱研究方面取得新进展！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a911e54109d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317514, encodeId=d2ee131e51444, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematology：来那度胺联合Obinutuzumab单抗治疗复发或难治性滤泡性淋巴瘤, objectType=article, longId=175098, objectId=5aae1e5098dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5aae1e5098dd, replyNumber=0, likeNumber=83, createdTime=2019-07-11, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5aae1e5098dd, moduleTitle=Lancet Haematology：来那度胺联合Obinutuzumab单抗治疗复发或难治性滤泡性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5aae1e5098dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：UM171扩增脐血干细胞移植

2019-11-09

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：如何评估肥大细胞增多症患者的预后？

2019-11-03

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Emanue－综合征胎儿一例（产前诊断、NT增厚）

2019-10-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

蓝鸟生物生产规范获EMA批准基因疗法Zynteglo准备上市！

2019-10-27

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

胡夕春教授：MONARCH plus研究——Abemaciclib给中国HR+/HER2-晚期乳腺癌患者带来新的希望

2019-10-24

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

2019 ESMO|内分泌治疗是激素受体阳性乳腺癌重要的治疗手段，Abemaciclib显著延长HR+/HER2-mBC患者PFS

2019-10-17

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：苏消安联合氟达拉滨用于异基因造血干细胞移植术前处理

2019-10-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

BMJ：2014-16年间EMA批准抗肿瘤药物临床关键试验偏倚风险研究

2019-09-25

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA：人用药品中应避免存在亚硝胺杂质

2019-09-17

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Stem Cells Int：干细胞片和Bio-Oss®骨颗粒复合物联合semaphorin 3A 可用于治疗2型糖尿病患者的骨丧失

2019-09-05

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：全膝关节置换的患者预防静脉血栓栓塞的更佳措施

2019-08-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet：Fremangezumab用于顽固性偏头痛预防

2019-08-22

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：纳武单抗联合伊达比星和阿糖胞苷可提高AML或高风险MDS患者预后

2019-08-11

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematology：Nivolumab联合一线化疗治疗急性髓系白血病

2019-08-10

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA建议批准Vitrakvi治疗NTRK基因融合的实体瘤患者

2019-07-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Aridis柠檬酸镓吸入剂AR-501治疗囊性纤维化肺部感染，喜获EMA孤儿药物指定

2019-07-24

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA药物警戒风险评估委员会将严格控制患者对甲氨蝶呤和环丙孕酮的服用

2019-07-19

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol:肺鳞癌新进展！上海市肺科医院周彩存团队在肺鳞癌免疫和基因图谱研究方面取得新进展！

2019-07-17

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematology & Oncology：肺鳞癌新进展！上海市肺科医院周彩存团队在肺鳞癌免疫和基因图谱研究方面取得新进展！

2019-07-15

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematology：来那度胺联合Obinutuzumab单抗治疗复发或难治性滤泡性淋巴瘤

2019-07-11

科室
- - 订阅+
  - 更多科室
工具
服务